UK Health Minister Abandons Plan for Smoke-Free 2030

Dec.13.2022
UK Health Minister Abandons Plan for Smoke-Free 2030
UK Health Minister cancels plan to make country smoke-free by 2030, keeping legal tobacco buying age at 18.

Health Minister Steve Barclay has announced the cancellation of a plan to make the country smoke-free by 2030, ending hopes of saving an additional 500,000 lives.


Sources from the White House have reported that they are abandoning plans to raise the legal age for tobacco purchases by one year each year until no one can purchase cigarettes.


This means that the minimum legal age for tobacco sales will remain at 18 years old. Anti-smoking activists argue that this is a missed opportunity to reduce smoking rates among young people by one-third.


Smoking is unlikely to be abandoned as a public health issue by any responsible government aiming for a smoke-free future by 2030, according to Deborah Arnott of the Action on Smoking and Health organization.


This is a government in the final stages that clearly lacks imagination and has lost its courage.


Former Minister of Health, Saeed Javed's goal was to lower the proportion of smokers in the population from over 13% to 5% within seven years, effectively defining a smoke-free target.


He commissioned Dr. Javed Khan, former head of the Barnardo's charity, to publish a report in June to fulfill the Conservative Party's 2019 manifesto promise of extending life expectancy by five years by 2035.


Dr. Khan stated that the government will only achieve its smoke-free goal within seven years if his measures are implemented.


He also hopes to see ministers invest £125 million to help people quit smoking, prescribe e-cigarettes, and ban outdoor smoking in areas where children gather.


Mr. Khan added, "We need to make smoking as difficult as possible and make quitting as easy as possible.


These intervention measures are crucial. There are no shortcuts, no quick fixes, and no excuses.


David Buck, from the King's Fund health think tank, commented on changes in age demographics, stating: "This is a very intelligent proposal. It can assist individuals, manufacturers, and retailers in planning for long-term changes.


Ms. Arnott supports raising the age limit to 21 years old. She claims that this measure would decrease smoking rates in the age group of 18-21 by 30%.


Smoking leads to 75,000 deaths each year in England and costs the NHS £2.4 billion.


Bob Blackman, the chairman of the All-Party Parliamentary Group on Smoking and Health and a Conservative MP, has stated that downplaying the UK's tobacco strategy could have adverse effects on reducing NHS waiting lists.


The number of deaths caused by tobacco is 30 times higher than the number of deaths caused by smoking-related illnesses.


Even though the Health Secretary Neil O'Brien told Members of Parliament 12 days ago that "we are considering the potential benefits of raising the age at which tobacco products can be sold, but age increase has been cancelled.


A spokesperson for the Department of Health and Social Care (DHSC) stated, "We are currently considering the extensive suggestions put forth in Khan's remarks.


2FIRSTS will continue to cover this topic and provide ongoing updates on the "2FIRSTS APP." Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
Philippines BIR Steps Up Illicit Vape Enforcement Ahead of Christmas Shopping
The Philippines’ Bureau of Internal Revenue is intensifying enforcement against illicit vape and tobacco products ahead of the Christmas shopping season, directing regional and enforcement offices to strengthen monitoring of production sites, warehouses, distribution channels and retail outlets. The BIR destroyed 240,550 illicit vape products in August with an estimated tax liability of about PHP1.53 billion. A nationwide tax-compliance operation in July also inspected 3,590 businesses involved in tobacco and vapor products.
Regulations
Sep.17 by 2Firsts Perspectives
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
North Carolina Tightens Vape Product Directory Enforcement, Expands State and Local Powers as Violators Face Fines, Product Seizures and License Suspension or Revocation
North Carolina Tightens Vape Product Directory Enforcement, Expands State and Local Powers as Violators Face Fines, Product Seizures and License Suspension or Revocation
North Carolina has expanded enforcement of its vapor product directory rules, authorizing more state and local law enforcement participation and establishing a task force led by the State Bureau of Investigation. The legislation requires at least one unannounced compliance inspection annually for retailers, distributors and wholesalers handling covered products. Penalties effective October 1, 2026, include civil fines of $500–$750 for a first violation and $1,000–$1,500 for repeated violations within 12 months, along with potential license suspension or revocation. Manufacturers may face penalties of $10,000 per unlisted product. The measures strengthen the product directory system established in 2024.
Regulations
Oct.28